15 August 2024
15 August 2024
Prescription-only Rejoyn has been priced at $50 to make it accessible to patients with major depressive disorder.
The company plans to trial its Alpha radiotherapy device in multiple indications such as brain, and recurrent lung cancers.
The MISHA system relieves symptoms of knee osteoarthritis by placing a small implant in the joint to offload pressure.
RenovoTX’s therapy is designed to reach the tumour more effectively than current intravenous chemotherapy treatments.
The FDA clearance comes after the UK health authorities recommended the app over traditional sleeping pills.
Sophia Genetics’ Sophia DDM platform processes NGS data to perform genomic analysis.
The Impella CP with SmartAssist devices in question were dispatched to customers despite failing lot inspections.
Clario contributed technology and expertise to the e-clinical outcome assessments during the development of the algorithms.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
